The Royal College of Veterinary Surgeons has released a series of photographs taken at its last council meeting on 7th March 2013.
Anyone for a photo-caption competition?
The full album can be seen here: http://www.flickr.com/photos/rcvs/sets/72157633046308352/
The RCVS has appointed Nicola South to the new role of Customer Experience Manager, a new role intended to help improve the experience for vets, veterinary nurses and the public in their dealings with the College.
Nicola said: "I'm extremely excited and proud to be joining the staff at the RCVS, and at such a significant time, just as the First-Rate Regulator initiative is underway, which will lead to a change of focus in how we deliver our services to meet all of our customers' needs. My arrival has been met by a staff made up of extremely dedicated and passionate individuals, and I'm really looking forward to working as a team to deliver an improved customer experience for everyone."
CEO Nick Stace said: "Nicola brings to the College a wealth of customer service experience gained from the hotel and tourism industries. Improving our customer service delivery is a priority, and I am delighted to have Nicola on board who will help to champion these improvements across the organisation."
Nicola joins the RCVS from Orbit Group Ltd, where she was Service Excellence Advisor for the East and South Region.
New research published in Epidemiology and Infection (Cambridge University Press) reveals that direct contact between badgers and cattle is rare, suggesting that it may be rare for bovine tuberculosis (TB) to be passed on through the two species meeting each other on pasture.
For the research, which was conducted by the Royal Veterinary College and the Food and Environment Research Agency, researchers investigated direct and indirect interactions between badgers and cattle by fitting automated high-tech proximity loggers to animals and placing base stations at badger latrines located on pasture, in an area of south-west England with a high-density badger population, over a period of 12-months.
Direct interactions (within 1.4 metres) between badgers and cows at pasture were very rare, with only four out of over 500,000 animal-to-animal contacts recorded between the two species.
Indirect interactions (visits to badger latrines) were far more frequent than direct contacts, with 400 visits by badgers and 1700 visits by cattle recorded. This suggests that indirect contacts might be more important than direct in terms of disease transmission at pasture.
During the study half of the badgers tested positive for TB, however the infection status of individual badgers did not affect the frequency or duration of their visits to latrines located on pasture grazed by cattle.
Bovine tuberculosis caused by infection with Mycobacterium bovis is endemic in cattle in parts of England and Wales and its control is hindered by the presence of infection in the European badger. While M. bovis is clearly transmitted between cattle and badgers, it is has not previously been known where, when or how often transmission occurs.
Dr Julian Drewe from the Royal Veterinary College who led the study, said: "Our findings reveal that direct contacts between badgers and cattle at pasture are surprisingly rare, despite ample opportunity for interactions to occur, suggesting that the two species may be ignoring or even actively avoiding one another. The study was conducted in an area with a high badger population, so it is likely that such direct contact will be even less frequent in areas of the country where there are fewer badgers.
"Indirect visits by both species to badger latrines were significantly more common than direct contacts between badgers and cattle, which suggests that these represent the more typical nature of interspecies contact. Future research aiming to quantify TB risk to cattle from badgers might be best to focus on indirect contacts occurring at latrines and on contacts occurring away from pasture, for example in farm buildings.
"This clearly has disease management implications, and more work is now needed in this area to look at how such contact can be limited, to reduce the number of cases of bovine TB in the future."
Vets4Pets has announced the opening of its 93rd practice in Kidderminster
The joint venture partnership was opened by husband and wife vets, Edd and Olivia Pring.
Edd and Olivia met at the Royal Veterinary College, where they both studied and graduated in 2002. Now married with two young children, Edd and Olivia wanted to be able to provide a secure future for their young family. Olivia said: "Being a vet is a time-consuming career choice; the hours can really eat into your personal time. Having the ability to open our own practice, spread the work load, not work weekends, have no out of hours AND get business support, means we will be able to do what we love and see our lovely boys grow up".
Vets4pets said it worked particularly hard to find the right property for the new branch. Mark Hanson, Partner Relationship Manager, Vets4Pets said: "Edd and Olivia had recently moved to Kidderminster to be close to family, knowing this we wanted to ensure their practice wouldn't be too far away for them to travel every day. We worked closely with them seeking out sites that would both suit their needs and the criteria that all Vets4Pets practices must adhere to, ensuring the practice's success."
Once a site was made available Edd and Olivia were able to get involved with the design elements of their new practice allowing them to have input on how the practice would function.
Edd said: "It's very nice to be in a purpose-built practice that you have been able to have input into the design and layout, but with the backup of people who have done it all before; learning from their mistakes! We really enjoyed meeting all the other local JVPs who seem like great people. It made us think, if they can do it so can we! Meeting the teams in Nottingham and Peter Watson and the teams in Guernsey was really useful; it was great to see Peter is still so passionate about the business and that we have a great, highly experienced team behind our new business".
Norbrook Laboratories Ltd has launched a second generation Eprinomectin Pour On solution with zero milk withhold and a 10 day meat withdrawal period. Eprizero, for beef and dairy cattle, is indicated for the treatment and prevention of a range of economically damaging gutworm and lungworm infections and external parasites in a pour on application. It offers zero milk withhold and an improved meat withdrawal period of 10 days. Andrew Hillan MVB MRCVS, Director of Veterinary Science, Norbrook Laboratories Ltd., said: "Norbrook has launched Eprizero to offer vets and farmers a more versatile alternative in the treatment of economically damaging worms and external parasites. The active ingredient in Eprizero, Eprinomectin, is both potent and fast-acting and is supported by independent studies which show increased milk yield, improved fertility and increased dry matter intake following treatment. With a zero milk and 10 day meat withdrawal and waterproof properties, Eprizero offers real versatility to vets and farmers in terms of when and where they treat. It is this versatility that we believe will make Eprizero the gold standard in anthelmintic treatment for prolonged infestations of gut worm and lung worm in both dairy and beef cattle." Eprizero is available in four sizes - 250ml, 1L, 2.5L and 5L - with a free 75ml gun supplied with the two larger pack sizes. It is administered using a 75ml dispensing gun to enable accurate application. Eprizero is registered for use in the UK and Ireland and is available to order from your local Norbrook Sales Representative.
The Royal College is calling for views on the Day One Competences required of newly qualified veterinary surgeons, via an online survey.
The survey can be accessed from the RCVS website (www.rcvs.org.uk/consultations), and can be completed until 31 May.
The College says that the survey is the first step in a review of the Day One Competences, which define the level to be expected of new veterinary graduates when they first qualify. The competences set out in broad terms what is required of new graduates at the end of their veterinary degree, and provide the foundation for curriculum design and student assessment in UK veterinary courses.
RCVS Council member David Catlow, who chairs the Working Party undertaking the review, said: "The Day One Competences are deliberately general as they aim to convey the important principles that all students must master by the time they graduate, regardless of the precise curriculum they have followed, so they are safe to practise in a range of veterinary contexts from day one after they graduate.
"As it is over ten years since these competences were confirmed, we are reviewing them to ensure they remain valid, and to seek to ensure they reflect current and likely future expectations."
The Working Party will report to the Education Policy and Specialisation Committee (EPSC), and includes representatives from the veterinary schools and the British Veterinary Association (BVA), as well as a recent veterinary graduate.
Since being confirmed by the RCVS, the Day One Competences have also been adopted across Europe, through the European Association of Establishments for Veterinary Education (EAEVE), and in countries such as Australia.
Zoetis, formerly Pfizer Animal Health has launched Ovatec Plus, which it claims will make equine faecal collection and in-practice worm count testing quicker and easier.
Ovatec Plus is designed to facilitate the in-house detection of worm burdens by enabling the coproscopic examination of parasite eggs, larvae and cysts. Zoetis says the built-in sample collection scoop allows for hands-off, quick, clean sample collection and controlled sample size, while the built-in cap, which can be written on for easy identification, snaps shut to seals the contents safely for contamination-free transport.
The system is based on zinc sulphate flotation technology, with a flotation time of ten minutes to provide rapid analysis. The Ova-Spin feature will break up difficult samples. The positive-locking filter chamber prevents any spill of test samples and reduces operator exposure to potential hazards. The overflow reservoir prevents overfills leaking onto the lab bench.
Zoetis says the high sensitivity and excellent specificity of Ovatec Plus enable informed treatment decisions to be made. A study has shown that samples proving negative with Ovatec Plus provide 95% certainty that the sample is <150epg and 100% certainty that the sample is <250epg, which means treatment may not be necessary1. Samples that prove positive, with one or more eggs seen, can be verified using a quantitative technique if needed, alternatively treatment may be indicated.
Ben Lacey, equine business unit manager at Zoetis, said: "Ovatec Plus is an excellent addition to our equine worm control portfolio. It's ideal for use in many test situations, giving a quick, easy and convenient solution."
To find out more, speak to your Zoetis Account Manager, call 0845 300 8034 or email CustomerSupportUK@zoetis.com.
Reference
The RCVS is seeking applications for a paid, part-time parliamentary internship from veterinary surgeons and students who have completed the third year of a veterinary degree.
Applicants are also required to demonstrate a commitment to the advancement of the veterinary profession in the UK.
The internship is to support the activities of Professor the Lord Trees, with the successful applicant expected to work three days a week whilst Parliament is sitting (around 150 days a year). The role is for one year, starting in October, and is London-based, with a salary of £15,000 (not pro-rata). A housing allowance may also be available.
Applicants should send a CV and covering letter to Lesley Evans, Royal College of Veterinary Surgeons, 62-64 Horseferry Road, London SW1P 2AF or email l.evans@rcvs.org.uk. The deadline for applications is 22 April 2013, with interviews taking place in late May/early June.
Further details about the role are available at www.rcvs.org.uk/about-us/work-for-us.
Petplan has announced the winners of its annual Veterinary Awards.
The awards recognise and celebrate staff and practices throughout the country that have delivered an exceptional level of care to the nation's pets and their owners.
Isabella von Mesterhazy, Petplan's Head of Marketing, said: "As the leader in the pet insurance market for over 35 years, we have a rich history of working with veterinary practices across the UK. The Veterinary Awards is a great way to celebrate the fantastic work that goes on helping keep pets healthy and their owners happy."
She added: "This year saw over 11,000 nominations which goes to show the appetite from both staff and clients for celebrating exceptional work. We had an outstanding selection of finalists and I'd like to congratulate all the winners who thoroughly deserve their awards."
The winners for each category are:
VET OF THE YEAR - Laura Pugh, Ashfield House Veterinary Hospital - Long Eaton, NottinghamWhat really stood out was Laura's willingness to go above and beyond the call of duty. As well as Laura's stressful day job she is very involved with the local community. Laura writes an animal column in her local neighbourhood magazine, runs evening talks on a variety of subjects and visits local schools.
VET NURSE OF THE YEAR - Catherine Raw, Broadleys Veterinary Hospital - Stirling, ScotlandCatherine's passion for her role within the practice and her dedication to providing the best service for her clients put her above the other finalists. Catherine is not only committed to her professional role of delivering the highest standard of clinical care for her patients and the best service for her clients, but she also devotes a lot of her own time to animal welfare. Catherine is a fantastic role model for her nurses.
VET SUPPORT STAFF OF THE YEAR - Vivienne Jeffs, Arvonia Animal Hospital - Cheltenham, GloucestershireVivienne's reliability, empathy and selflessness really stood out for the judges. Whether it is knowing the name of a pet owner during telephone conversations, or entertaining toddlers in the waiting area, Vivienne is the type of receptionist vet surgeries dream of. The practice would not be the same without her according to those that nominated her.
VET PRACTICE OF THE YEAR - Bridge Veterinary Surgery - Highbridge, SomersetThe practice's hard work and dedication to their clients really impressed the judges. The practice is open 24 hours a day and the dedication the veterinary, with a small practice of only four staff members, it is a particularly well deserved award.
VET PRACTICE MANAGER OF THE YEAR - Cery Lawson-Tankred, Golden Valley Veterinary Hospital - Nailsea, SomersetCery has worked at Golden Valley for over five years, during which time the practice has seen a large degree of upgrade and reinvigoration. Investments made in new equipment and facilities have meant improved care for an expanding array of animals that come through the surgery doors. It was clear to the judges that Cery is the glue that holds the Golden Valley Veterinary Hospital together.
The BSAVA and Vets Now have signed a partnership agreement to develop a new postgraduate certificate in emergency and critical care (ECC).
The programme, which will follow the same broad structure as BSAVA's existing postgraduate certificate, will take its first group of students in May 2014.
Prof Michael Day, pictured above with Amanda Boag at BSAVA, said: "This is an exciting development to develop a qualification which will be relevant and accessible to vets in practice."
Amanda Boag added: "The combined expertise of both organisations will result in an engaging and high quality qualification in this field."
Pets at Home has announced the acquisition of the joint venture practice business, Vets4Pets, adding 93 stand-alone veterinary practices to the 116 in-store practices it already operates under the Companion Care brand.
Providing veterinary and grooming services to consumers is seen as the way for the retailer to overcome competition from the Internet.
Nick Wood, CEO of Pets at Home said: "The expansion of our veterinary business is a key element of our growth strategy for Pets at Home, providing additional services to our customers within our stores or close to our customers' homes. The acquisition of Vets4Pets is an important step in the delivery of this strategy. Vets4Pets is highly complementary to Companion Care, sharing fundamental beliefs and values, and is an excellent strategic fit for Pets at Home. I am delighted that Peter Watson has agreed to stay with the business. His knowledge and experience will be invaluable as we continue to build our veterinary business with both stand-alone and in-store practices. He will work closely with Jane Balmain, the Managing Director of our Companion Care business as we integrate the two businesses."
Peter Watson, Founder and CEO of Vets4Pets said: "Pets at Home holds a unique place in the retail landscape, built on a strong identity and a real passion for people and pets. It is clear to me that Nick and his team have a similar vision for their veterinary business. I'm delighted to be working with Nick to continue to expand the veterinary business by offering attractive joint venture opportunities for vets in stand alone locations to complement the offering in Pets at Home stores."
Companion Care MD, Jane Balmain added: "Companion Care and Vets4Pets each enjoy a strong reputation among both vets and customers. Both businesses have a common business model, offering joint venture partnerships with vets. I am looking forward to working alongside Peter as we bring the businesses together, continue to expand our joint venture partnerships and accelerate our growth."
Vets4Pets' UK operational centre will remain in the East Midlands, with its support functions being split between Companion Care's operation in Oxfordshire and Vets4Pets' Guernsey office.
The BSAVA reports the highest ever attendance at Congress this year: 6,178 veterinary surgeons, nurses, practice managers and students, 6% cent higher than in 2011 (the last time the BSAVA hosted its own Congress).
According to the association, a significant number of international delegates attended this year with almost 60 countries represented - notably Scandinavia (186 delegates), Germany (56), the Netherlands (40) and the USA (31).
Other highlights included:
Outgoing BSAVA president Mark Johnston said the event was the highlight of his presidential year: "Last year we showed the world how well the BSAVA can organise a major veterinary congress. But what is pleasing is that the momentum we gained from hosting the World and European meetings has continued into this year.
"We had more delegates in 2013 than in the last purely BSAVA Congress two years ago and to accomplish that in these difficult financial times is a remarkable achievement."
Newly inducted BSAVA president Michael Day (top right) said he was looking forward to extending the international aspect of BSAVA. The Australian-born Professor who has lived in the UK for well over two decades said: "BSAVA has made huge contributions to veterinary practice in the UK, and already has a global reputation for Congress and publications - I believe we have such a wealth of resources and so I am convinced we have so much more to offer the world".
Six individuals have been announced as the winners of the second annual Ceva Animal Welfare Awards, honoured for their contributions to the prevention and reduction of animal welfare problems in the UK and abroad.
All winners were originally nominated by friends, colleagues or family. The judging panel consisted of panel chairman and veterinary surgeon Chris Laurence MBE, Ross Tiffin of the International Cat Care (formerly the Feline Advisory Bureau), Dennis Baker, OBE, Chief Executive at Wood Green, the Animal Charity and media vet, Joe Inglis. Marc Abraham also assisted in the Volunteer categories.
Dr. Pascal Raoul, Ceva's Head of Global Pharmaceuticals, said: "Ceva is delighted to host these Animal Welfare Awards as they help to highlight the incredible affection and care that people have for animals. With 6 billion people living in megacities in the future, companion animals will often be their major link to nature. The benefits that animals have on improving human health are well documented; in turn we all have a duty to protect them and this evening we have seen some of the best examples, from professionals, members of the public, young and old as to how that should be done."
Timothy Phillips, a Plymouth-based vet from the Elm Veterinary Group (above right), was awarded the Chris Laurence Vet of the Year Award for his 15 years of charitable work in the Greek Islands with Friends of the Strays of Greece. Tim performs surgeries and other treatments, helping to establish a re-homing system, with dogs fully vaccinated and declared healthy by the vets before being flown out of Greece.
Veterinary Nurse Scott Parry of Bridge Veterinary Surgery was awarded Welfare Nurse of the Year for his work with the RSPCA's Brent Knoll Animal Centre. Scott has spent hours of his own time raising funds and helping with the rehabilitation of a number of traumatised dogs. He also recently assisted in an RSPCA visit to a travellers' camp to vaccinate more than 50 dogs following an outbreak of Parvo Virus on the site.
Other award winners included Logan McKerron, aged 6, who was awarded Young Person of the Year for his fundraising for Hearing Dogs for Deaf People; Kim Taylor, co-founder of the charity Animal Care Egypt, was awarded the Charity Professional of the Year accolade for her work setting up a large animal hospital helping more than 26,000 animals every year; Faye Stacey of People4Ponies in Devon was awarded the UK Volunteer of the Year Award for the large part she has played in stopping ear cutting, notching and tagging of equines in the UK; Jen White has been named International Volunteer of the Year for her work with the Gambia Horse and Donkey Trust.
Novartis Animal Health has announced that it has assumed marketing responsibilities for the joint health supplement Cosequin in the United Kingdom and Ireland.
Cosequin, which contains glucosamine and chondroitin sulfate, is available in a range of presentations for dogs, cats, and horses.
The product, which was previously marketed by MSD, is the leading joint health supplement among veterinary surgeons in the US and Europe.
Novartis says Cosequin is an important addition to its Orthopaedic Health Category, which in 2009 introduced Onsior (robenacoxib), the first tissue-selective pain relief for cats and dogs.
Gaynor Hillier, General Manager UK & Ireland Novartis Animal Health said: "Our strategic intent is to expand our presence in orthopaedic health to address prevention, diagnosis, and treatment in a more comprehensive manner. Cosequin represents an important step toward achieving this objective".
Cosequin is available from Novartis Animal Health in the United Kingdom and Ireland, from licensed veterinary wholesalers. For more information on Cosequin, contact your Novartis Animal Health Territory Manager.
The Royal College is inviting veterinary surgeons to the first-ever Virtual Question Time, which is being held online with The Webinar Vet, from 8-9.30pm on Wednesday 24 April.
Lizzie Lockett, Head of the RCVS Communications Department said: "This is an ideal opportunity to put your burning questions to members of the RCVS Officer team and to VN Council. Our regular Question Time meetings are popular, so we are following their format by asking delegates to set the agenda via their choice of questions. This time there is the extra advantage that busy vets and nurses can take part from the comfort of their own homes. If the Virtual Question Time proves successful, we may hold these events regularly."
The meeting will be run as a free, live-audio webinar. RCVS President Jacqui Molyneux will open proceedings, and introduce the panel, before answering questions from the participants.
Questions may be put to the College in advance and can also be submitted as discussion unfolds on the night. These can be on any issues affecting the veterinary and veterinary nursing professions - there is no set agenda - and might range from the First Rate Regulator initiative, new vet schools, veterinary nurse training and clinical governance, to proposed changes to the Practice Standards Scheme and recent amendments to the Veterinary Surgeons Act.
The session will also be recorded so those unable to attend on the night can still listen afterwards.
The meeting can be counted towards continuing professional development for veterinary surgeons and veterinary nurses. Registrations and questions can be submitted online at http://thewebinarvet.com/rcvs/#.
Virbac has announced the launch of My Virbac, a new website offering a range of business, marketing and technical services for veterinary professionals.
The main elements of My Virbac are:
Virbac Product Manager, Ms Victoria Hudson said: "Virbac was one of the pioneers of the concept of practice support and the services we already offer are highly valued by our customers. In developing My Virbac, we're taking things to a new level. We've worked with business and veterinary experts to develop a practical and helpful range of services which will make a real difference to practices that use them. We plan to add additional services and tools on a regular basis.
"As the veterinary sector becomes increasingly competitive, providing an outstanding clinical service is no longer enough. Practices must also be well-run businesses, with a strong focus on marketing and client retention. Taking advantage of the services and tools available on My Virbac will help practices to ensure they are well placed to succeed even in difficult times."
To access Virbac's services platform, practices and individuals can register at www.my-virbac.co.uk.
The Born Free Foundation, British Veterinary Association, Captive Animals' Protection Society and the RSPCA have welcomed the Government's draft legislation to ban the use of wild animals in circuses in England, to be implemented in 2015.
The groups, which have worked closely together for a number of years on the campaign to seek an end to the use of wild animals in big tops in the UK said that they were "delighted" to see the ban brought forward in concrete terms.
A spokesperson, talking on behalf of all four leading organisations said: "We are pleased to see that the Government appear to have come good on their promise to ban the outdated practice of using wild animals in circuses.
"We have long argued that the complex needs of wild animals cannot be met in a travelling circus environment and were disappointed when the Government introduced a licensing regime earlier this year which appeared to legitimise a practice which we, and our hundreds of thousands of supporters, want to see abolished altogether.
"We are looking forward to seeing the ban fully implemented at the earliest opportunity".
BVA President Peter Jones said: "Whilst there are only 20 wild animals kept by two licensed circuses in the UK, their welfare is emblematic of the way we treat all animals."
The groups said that they would work to support Government in the formal enactment of the Bill and the Born Free Foundation and the RSPCA reiterated their pledge to offer to find safe homes for life for all wild animals currently being used in English circuses.
Animalcare Ltd has launched Marbocare (marbofloxacin) 100mg/ml solution for injection, a third-generation fluoroquinolone for the treatment of E.coli mastitis and bovine respiratory disease (BRD) in cattle, and Metritis Mastitis Agalactia in pigs.
The company highlights the product's unique flexible dosage regimen of once daily injections for 3 days against E.coli mastitis and BRD, plus a single intramuscular (IM) high dose (8mg/100kg) for BRD.
Animalcare says this regimen, coupled with the flexibility of administration afforded by all three injection routes (intravenous IV, subcutaneous SC and IM), a low volume dose and good syringeability, all combine to offer ease of use; resulting in a reduction in handling and less stress for the cattle.
Developed for veterinary use only, Marbocare has broad spectrum activity against Gram+ve and Gram-ve pathogens. Animalcare says the product is especially effective against E.coli mastitis and the key bacterial pathogens associated with BRD, as well as M.bovis.
Marbocare has milk withdrawal times of 36 hours after the last treatment following the 3 day course and 72 hours after a single shot for BRD. Meat withdrawal is 6 days after multiple injections and 3 days after the single shot.
Marbofloxacin has proven efficacy in a comparative international, multi-centre, controlled, randomised field trial1 in 62 dairy cows with E.coli mastitis. Marbofloxacin cure rates were significantly higher than the control product. In respiratory disease it showed a more rapid clinical response in comparison to tilmicosin2, ceftiofur3 and oxytetracycline4. Marbofloxacin was shown to be well tolerated, leading to a fast return to appetite, liveweight gain and associated welfare benefits.
Marbocare is also licensed in the treatment of Metritis Mastitis Agalactia syndrome in pigs, given by IM injection, with a 4 day meat withdrawal.
Tony Liepman, Product Manager from Animalcare said: "Marbocare is competitively priced whether used on its own or alongside a single-dose anti-inflammatory such as Emdocam (meloxicam)."
Marbocare is a POM-V licensed product presented in 50 and 100ml multi-dose vials.
References
Virbac has launched Inflacam, a meloxicam-based NSAID for the alleviation of pain in both acute and chronic musculo-skeletal disorders in dogs and horses.
Inflacam is presented both as an oral suspension and as a chewable tablet for dogs. The suspension is available in 200ml, 100ml, 42ml and 15ml sizes with a measuring syringe provided. The tablets come in two sizes - 1 mg and 2.5 mg - and are available in packs of 100. It is available for horses as an oral suspension.
Virbac Product Manager Chris Geddes MRCVS, said: "Virbac is well known for launching innovative products in areas such as dermatology and reproduction but we also aim to support practices by offering tried and trusted practice 'standards' for everyday use. Inflacam fits this brief well - meloxicam is the most commonly-used NSAID in dogs and we are delighted to add it to our range."
For more information contact your territory manager or call Virbac on 01359 243 243.
Ceva Animal Health has launched Marboxidin chewable tablets for dogs and cats for the treatment of micro-organisms susceptible to marbofloxacin, including skin and soft tissue infections (in cats and dogs), respiratory tract infections (in dogs and cats) and urinary tract infections (in dogs).
Containing marbofloxacin as its active ingredient, Marboxidin has a taste-masking lipid coating to ensure that its bitterness is not detected. In palatability trials over 90% of dogs and 80% of cats voluntarily consumed Marboxidin chewable tablets from the hand or in food1. Ceva says that Marboxidin is also very cost-effective, with an ongoing discount using the new CevaSave rebate scheme.
Marboxidin chewable tablets are available in three tablet sizes (5mg, 20mg and 80mg).
For further details, contact your Ceva Territory Manager or telephone the customer support team on (01494) 781510.
The WSAVA's Global Nutrition Committee (GNC) has launched a Nutrition Toolkit for veterinary professionals.
The non-branded toolkit contains the following materials:
The toolkit is available for download at http://wsava.org/nutrition-toolkit.
Based on its importance to overall health, the WSAVA is campaigning to have a nutritional assessment confirmed as the fifth vital assessment in a standard physical examination and for the veterinary healthcare team to provide nutritional recommendations for each animal as an integral component of patient care.
The launch of the Nutrition Toolkit follows on from the Global Nutrition Committee's first initiative, the creation of a set of Nutrition Guidelines in 2011. These were aimed at helping veterinary professionals and pet owners ensure that pets are fed according to an optimal and individually tailored nutrition plan. According to WSAVA, they have been successful, securing endorsements from 19 veterinary organizations in 16 countries. They have been translated into ten languages and are available for download at http://www.wsava.org/guidelines/global-nutrition-guidelines.
GNC Co-Chair Dr Marge Chandler said: "Research shows that more than 90% of pet owners would like nutritional advice but fewer than 15% feel they receive it. In some parts of the world, pet malnutrition remains a major challenge, while in many other countries, pet obesity is an increasing problem. In addition, there is confusion about optimal nutrition because there is now so much conflicting and inaccurate information available online.
Our Nutrition Toolkit is designed to help the veterinary healthcare team address nutrition at every patient visit and to advance the central role of the veterinary healthcare team as the expert source of nutrition information."
Owners of hyperthyroid cats say they would rather veterinary surgeons prescribed the appropriate dosage for their pets than have an easy way to administer the medicine, according to new research carried out by feline expert Dr Sarah Caney BVSc PhD DSAM (Feline) MRCVS.
111 cat owners were questioned for the research, which was supported by Dechra Veterinary Products and has been accepted for publication in the Journal of Feline Medicine and Surgery.
Dechra says the results of the study challenge long-held perceptions, and should encourage a reappraisal of the approach to oral anti-thyroid medication:
89% of cat owners agreed with the statement that it 'was more important to me that the vet prescribes the most appropriate dose for my cat than that they provide me with an easy method of administering the medicine.'
Dr Caney said: "The survey has shown that cat owners are not a barrier to prescribing twice daily medication. Their overwhelming drive is to provide the best level of care that they can.
"From an owner perspective, the ideal anti-thyroid medication offers low doses and a variety of dosing strategies to ensure that each individual cat receives the dose they need and no more."
The findings revealed that 'once daily treatment' was not ranked as the most important statement on dosing by any of the owners and that only 21% of owners who had experienced oral dosing of their cat described the process as either 'tricky' or 'very difficult'.
Craig Sankey, Brand Manager for Felimazole at Dechra Veterinary Products, said: "We are very pleased to have supported such an important piece of independent research relating to feline hyperthyroidism which challenges some of the assumptions made about owner needs.
"Ease of administering the medicine is not the overwhelming issue for owners of cats with hyperthyroidism - administering the correct dose is. In fact, 79 % of cat owners questioned were happy to give pills twice a day if necessary."
To see the latest research in full, please visit www.dechra.co.uk/hyperthyroidism
Boehringer Ingelheim Vetmedica has launched Pexion (imepitoin) a novel treatment for canine idiopathic epilepsy.
Canine epilepsy can affect up to 5% of dogs6. In most dogs diagnosed with idiopathic epilepsy no underlying cause for the seizures can be found. While the condition can affect any dog, it is more common in young (one to five year old), purebred dogs such as Labradors, Golden Retrievers, German Shepherds, Boxers, Vizlas, Beagles, English Springer Spaniels, Irish Setters, Poodles and Dachshunds.
Boehringer says Pexion has a highly targeted mode of action1-3 to suppress a dog's seizures. It starts to work within a few hours and reaches steady state within three days4,5. Boehringer claims this will make it easier to stabilise epileptic patients. It also says there is no evidence of hepatotoxicity or liver-associated enzyme elevation, so repeated blood tests for liver enzymes or therapeutic levels are no longer required.4,5
Pexion is available in 100 mg and 400 mg tablets. The tablets are white, scored and divisible in half. Both tablet strengths are available in 100 tablet packs from veterinary wholesalers.
Jemima Mead, brand manager at Boehringer said: "Pexion is a ground-breaking new product which gives vets a new first-line treatment option for dogs with idiopathic epilepsy, improving the lives of newly diagnosed epileptic dogs and their owners by reducing the number of seizures and their impact on the patient's life".
To support the launch of the new product, Boehringer hosted an epilepsy webinar presented by neurologist Dr Holger Volk DVM PhD DipECVN FHEA MRCVS, recognised RCVS and European Specialist in Veterinary Neurology. The webinar is now available on demand at www.bi-academy.co.uk.
For further information on Pexion visit www.pexion.co.uk, contact your local Boehringer Ingelheim territory manager or telephone +44 (0)1344 746959.
Invicta Animal Health has launched EthyCalm Spray, a cryoanalgesic for minor procedures.
The active ingredient, ethyl chloride, acts as a local analgesic (pain relief) when sprayed or wiped onto the skin.
According to the company, the product is effective in a few seconds and works for a few minutes until the skin warms up again. This makes it suitable for such things as venepuncture, tick removal or placing of PVC's, where it should help reduce stress for the patient and the practitioner.
Ethycalm is presented in a 50ml vial which provides up to 100 applications.
Rob Watkins, Managing Director of Invicta, said: "We are delighted to launch EthyCalm. During theatre training sessions for our product, ChloraPrep, we realised that the busy nurse doesn't have time to use traditional analgesia methods such as creams. They needed something instant yet cost-effective. Seeing the widespread use of ethyl chloride in places like Great Ormond Street Hospital, it was obvious that this product needed to be made available to veterinary practices".
For further information see www.invictavet.com or phone 01403 791313
Novartis Animal Health has announced the launch of a new campaign called Prepare, Predict, Prevent and designed to raise awareness of blowfly strike management in sheep.
The campaign will include new industry research, an expert-led report, and information tailored to farmers, veterinary surgeons and SQPs. The campaign is aimed at improving awareness of blowfly strike management, with a particular focus on prevention.
In the UK, blowfly strike (myiasis) occurs on over 80 per cent of sheep farms2. If untreated, strike can severely affect the welfare of infested sheep, and may result in death. For farmers, poor management of blowfly strike brings economic costs in terms of the loss of animal, production losses and in terms of treatment and control of the disease, which is easily spread.
Furthermore, previous research from the University of Bristol4, which simulated the pattern of parasite growth in different climate-dependent environments, showed that an increase in average temperature of 3 degrees Celsius would be enough to quadruple the incidence of strike in ewes and double the rate in lambs. This is a growing concern, with climate change models for the UK suggesting that over the next 50 years summer temperatures are set to increase by 1.5 degrees Celsius and winter temperatures by 2.5 degrees Celsius5.
Research conducted at the 2013 Animal Health Distributors Association (AHDA) Annual Conference indicated that, in the past five years, many believe the blowfly strike season is lasting longer and beginning earlier in the year, with the majority of early reported cases occurring unexpectedly in March. The findings have prompted a wider survey from Novartis Animal Health, which is urging SQPs, farmers and key opinion leaders nationwide to contribute answers at: www.farmanimalhealth.co.uk/fleecebind-questionnaire.
Katherine Openshaw, Ectoparasiticides Category Manager at Novartis Animal Health, said: "This has always been a serious issue for the sheep industry and elevated temperature is likely to bring about increased levels of blowfly strike and a longer season.
"We recognise the need to evolve attitudes towards parasite control and to provide farmers and prescribers with the knowledge and tools needed to facilitate a better management of blowfly strike. The 'Prepare, Predict, Prevent' campaign is all about simple, yet effective, measures to prevent the occurrence of blowfly strike, which can be enough to ensure farmers are protected from the potentially devastating impacts of flock infestation, offering season peace of mind.
"We have developed a range of materials to aid prescribers in promoting preventative solutions to farmers; these include farmer leaflets, posters and counter displays. We will also be offering training support so prescribers are best equipped to help farmers make informed decisions about preventative blowfly solutions."